Anju Software, a Valsoft Corporation portfolio company, is a customer-first organization serving the global life sciences market. While continuing to deliver our suite of established solutions—TrialMaster, CTMS Master, and AutoEncoder—Anju's new AI focused products are focused on accelerating clinical research and driving innovation across its customer base. For more information, please visit https://www.anjusoftware.com/

Prevail InfoWorks is a global full-service CRO/FSP with a unique combination of clinical operations expertise, the full suite of proprietary clinical trial systems, and advanced analytics. With experience across eight FDA product approvals, Prevail delivers end-to-end trial services and digital tools for clinical analysis through the Single Interface™, providing single sign-on to all internal and third-party data. This real-time integration of clinical, diagnostic, operational, and financial information makes drug development easier, faster, and less risky. For more information, please visit https://prevailinfoworks.com/

IMO Health is a clinical data intelligence business improving how data is used across the healthcare landscape. With support from industry-leading NLP experts and data scientists, Our solutions for life sciences deliver reliable insights from medical literature, patient data, and real-world evidence along with standardized codes and precise cohort definitions.For more information, please visit https://www.imohealth.com/

Weiss-Aug MedPharma specializes in the manufacturing of high-quality medical device components, assemblies, and finished products. With over 50 years of experience and a deep commitment to quality, we help leading medical device companies bring life-changing innovations to market with speed, accuracy, and full regulatory compliance. Our advanced manufacturing capabilities, robust quality management systems, and engineering expertise make us a trusted extension of your team. Whether you’re scaling a breakthrough device or refining a complex assembly, we provide the technical excellence and responsive service you need to succeed in today’s demanding healthcare environment. With capabilities spanning engineering design and development, precision machining, injection molding, metal stamping and value-added assembly solutions, we provide a flexible engagement model to bring your medical innovations to life. Our ISO-certified facilities ensure the highest standards in quality, traceability, and compliance. Partner with us to accelerate innovation, reduce risk, and deliver exceptional outcomes—because when it comes to patient safety and performance, only the highest standards will do.

PharmaJet’s mission is to enable greater access to life improving pharmaceuticals. We are committed to helping our partners realize their research and commercialization goals while making an impact on public health. PharmaJet’s Needle-free Injection Systems provide increased vaccine effectiveness, a preferred patient and caregiver experience, and a proven path to commercialization. They are also safe, fast, and easy-to-use. The Stratis® System has U.S. FDA 510(k) marketing clearance, CE Mark, and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously. The Tropis® System has CE Mark and WHO PQS certification for intradermal injections. For more information visit www.pharmajet.com.

Tilda Research builds AI teammates that drastically simplify trial management for sites, CROs and sponsors. Designed to seamlessly integrate into your clinical software ecosystem, it automates routine tasks, optimizes collaboration, and provides real-time insights to help you supercharge your trial. Welcome to the age of AI-assisted clinical trial management. For more information, please visit https://tilda.bio/

Premier Applied Sciences is the data and research division within Premier. Our sharp focus on differentiated data, groundbreaking research and clinical trials innovation helps drive speed to value – delivering efficiencies, lowering costs, reducing health disparities and improving patient outcomes. With the industry’s largest outpatient chargemaster database and deep expertise drawing actionable conclusions from the data, we help organizations solve tough challenges and open new doors for meaningful improvements in healthcare. For more information, please visit https://premierinc.com/ 

Curia works with sterile APIs, potent and cytotoxic compounds, and controlled substances – from clinical to commercial scale – at four sterile drug product facilities. Our expertise includes modality agnostic, first principle formulation development designed around target product profile. Curia support the development of solutions, suspensions, emulsions, lipid nanoparticles, and lyophilized dosage forms for various formats, including vials, pre-filled syringes, and cartridges.

INCOG BioPharma is a fill/finish CDMO providing end-to-end solutions for clinical through commercial phase sterile injectable drug products for the global biopharmaceutical market. Our facility is FDA-approved and Annex 1-compliant and uses the latest technology to provide tailored manufacturing solutions. We fill high-value biologics and peptides into syringes, vials, and cartridges, and offer autoinjector assembly, final packaging solutions, and in-house analytics.

Deeply rooted in community oncology centers globally, The START Center for Cancer Research provides access to specialized preclinical and early-phase clinical trials of novel anti-cancer agents. START clinical trial sites have conducted more than a 1,000 early-phase clinical trials, including for 45 therapies that were approved by the FDA or EMA. START represents the world’s largest roster of early-phase Principal Investigators (PIs) across its ten clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. Learn more at STARTresearch.com.

Hera Health Solutions, Inc. is a pharmaceutical device company specializing in the research, development, and commercialization of long-acting therapeutics through a proprietary nanotechnology-enabled bioerodible drug delivery platform. Our advanced nanofiber-based system enables precise control of drug release kinetics and enhanced bioavailability. We partner with pharmaceutical and biotech companies to accelerate reformulation programs with scalable, GMP-ready manufacturing for rapid clinical and commercial translation, and actively co-develop and license innovative long-acting drug delivery solutions.

Serina Therapeutics is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina’s POZ Platform™ provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Serina is headquartered in Huntsville, Alabama on the campus of the HudsonAlpha Institute of Biotechnology.